Suffering from Nail and Scalp Psoriasis?

Eli Lilly is conducting a US-Based Observational Study of Nail and Scalp Psoriasis Improvement in Patients Treated with Ixekizumab (Taltz)

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol #  I1F-MC-B018

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.

Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.